Australia's CurveBeam rises on Chinese approval of medical imaging device
13/10/2026 24:39
BUZZ-Australia's CurveBeam rises on Chinese approval of medical imaging device ** Shares of Australia's CurveBeam AI CVB.AX rise as much as 35% to A$0.027, their biggest intraday pct gain since September 16
** Stock hits its highest level since September 24
** Medical equipment maker says its HiRise weight-bearing specialised medical imaging has received approval from China's National Medical Products Administration
** Stock down over 60% this year, including the day's move
(Reporting by Rajasik Mukherjee in Bengaluru)
Recent news on Curvebeam AI
See all newsAustralia's CurveBeam rises on Chinese approval of medical imaging device
Brief: Curvebeam AI Seeks Trading Halt
Australia's CurveBeam AI shares double in value on FDA nod for CT scan tech
Australia's CurveBeam AI on track for best day in 3 weeks on premium placement
Brief: Curvebeam AI Secures A$5 Million Placement, A$1 Million Share Purchase Plan